|
End-of-day quote
Egyptian Exchange
2026-08-20
|
5-day change | 1st Jan Change | ||
| 1.520 EGP | +2.70% |
|
-1.94% | +33.33% |
| 05-17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 02-19 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
EPS & Dividend: Macro Group Pharmaceuticals (Macro Capital) S.A.E
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Dividend per Share 2 | - | 0.03 | 0.04 | 0.06 |
| Rate of return | - | 1.97% | 2.63% | 3.95% |
| EPS 2 | 0.2 | 0.06 | 0.09 | 0.11 |
| Distribution rate | - | 50% | 44.4% | 54.5% |
| Reference price 2 | 1.140 | 1.520 | 1.520 | 1.520 |
| Nbr of stocks (in thousands) | 570,206 | 570,206 | - | - |
| Announcement Date | 2/19/26 | - | - | - |
1EGP in Million2EGP
Estimates
Past dividends: Macro Group Pharmaceuticals (Macro Capital) S.A.E
| 2025-11-16 | Ex-dividend date - 0.21811 EGP | 00:00 |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | - | - | 25.33x | - | 0.66x | |
| 0.55% | 0.62% | 35.74x | 22.68x | 12.95x | |
| 1.99% | 2.08% | 30.06x | - | - | |
| 2.59% | 2.72% | 33.82x | -371.14x | 7.82x | |
| 2.66% | 2.72% | 20.93x | 7.52x | 4.96x | |
| 2.75% | 2.87% | 22.59x | 6.36x | 5.81x | |
| 1.99% | 2.11% | 21.37x | 4.8x | 4.4x | |
| 2.3% | 2.43% | 27.79x | 20.99x | 7.17x | |
| 3.75% | 3.71% | 13.71x | 5.7x | 4.87x | |
| 2.26% | 2.32% | -44.65x | 9.95x | 6.45x | |
| Average | 2.31% | 2.4% | 18.67x | -36.64x | 6.12x | |
| Weighted average by Cap. | 1.89% | 1.98% | 25.51x | -42.70x | 8.51x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
